GRAIL Inc

GRAL14 Dec 2024
Healthcare
$20.98
+0.04 (+4.26%)
Lowest Today
$20.41
Highest Today
$21.76
Today’s Open
$20.98
Prev. Close
$20.78
52 Week High
$23.44
52 Week Low
$12.33
To Invest in GRAIL Inc

GRAIL Inc

Healthcare
GRAL14 Dec 2024
+0.04 (+4.26%)
1M
3M
6M
1Y
5Y
Low
$20.41
Day’s Range
High
$21.76
20.41
52 Week Low
$12.33
52-Week Range
52 Week High
$23.44
12.33
1 Day
-
1 Week
-4.02%
1 month return
+30.23%
3 month return
+47.44%
6 month return
+1.71%
1 Year return
-
3 Years return
-
5 Years return
-
10 Years return
-

Market Status

Fundamentals
Market Cap
687.47 mln
PB Ratio
0.27
PE Ratio
0
Enterprise Value
-93.89 mln
Total Assets
3913.81 mln
Volume

Company Financials

Fund house & investment objective

Company Information
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Organisation
GRAIL Inc
Employees
1360
Industry
Diagnostics & Research
CEO
Mr. Robert P. Ragusa
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step